Apolipoprotein e e4 allele is associated with more rapid motor decline in older persons

Alzheimer Disease and Associated Disorders

Volumn 23, Issue 1, 2009, Pages 63-69

  Buchman, Aron S ^a,b   Boyle, Patricia A ^a,b   Wilson, Robert S ^a,b   Beck, Todd L ^c   Kelly, Jeremiah F ^a,b   Bennett, David A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Neurological Sciences ^*

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

4 allele; Aging; Apolipoprotein E; Motor decline; Motor function; Muscle strength

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ARTICLE; BODY MASS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE STRENGTH; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN E4; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MOTOR ACTIVITY; MUSCLE STRENGTH;

EID: 62949091598     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31818877b5     Document Type: Article

References (37)

1. Al Snih S, Markides KS, Ray L, et al. Handgrip strength and mortality in older Mexican Americans. J Am Geriatr Soc. 2002;50:1250-1256.
2. Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;33 2:556-561.
3. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. Can Med Assoc J. 2006; 174:801-809.
4. Cesari M, Leeuwenburgh C, Lauretani F, et al. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti Study. Am J Clin Nutr. 2006;83:1142-1148.
5. Mahley RW, Weisgraber KH, Huang Y. Inaugural article: apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's Disease. Proc Natl Acad Sci. 2006;103:5644-5651.
6. Houlden H, Greenwood R. Apolipoprotein E4 and traumatic brain injury. J Neurol, Neurosurg, Psychiatry. 2006;77: 1106-1107.
7. Wilson RS, Schneider JA, Barnes LL, et al. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol. 2002;59:1154-1160.
8. Sudlow C, Martinez Gonzalez NA, Kim J, et al. Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage?: systematic review and meta-analyses of 31 studies among 5961 cases and 17 965 controls. Stroke. 2006;37: 364-370.
9. Melzer D, Dik MG, van Kamp GJ, et al. The apolipoprotein E E4 polymorphism is strongly associated with poor mobility performance test results but not self-reported limitation in older people. J Gerontol A Biol Sci Med Sci. 2005;60: 1319-1323.
10. Carmelli D, DeCarli C, Swan GE, et al. The joint effect of apolipoprotein E Epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. J Gerontol A Biol Sci Med Sci. 2000;55:M103-M109.
11. Bennett DA, Schneider JA, Buchman AS, et al. The rush memory and aging project: study design and baseline characteristics of the study cohort. Neuroepidemiology. 2005; 25:163-175.
12. Dik MG, Jonker C, Bouter LM, et al. ApoE-Epsilon4 is associated with memory decline in cognitively impaired elderly. Neurology. 2000;54:1492-1497.
13. Bennett DA, Schneider JA, Aggarwal NT, et al. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006;27:169-176.
14. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's Disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task force on Alzheimer's Disease. Neurology. 1984;34:939-944.
15. Boyle PA, Wilson RS, Aggarwal NT, et al. Parkinsonian signs in subjects with mild cognitive impairment. Neurology. 2005;65:1901-1906.
16. Buchman AS, Boyle PA, Wilson RS, et al. Physical activity and motor decline in older persons. Muscle Nerve. 2007;35: 354-362.
17. Buchman AS, Wilson RS, Boyle PA, et al. Motor function and mortality in older persons. J Am Geriatr Soc. 2007; 55:11-19.
18. Louis ED, Tang MX, Schupf N, et al. Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol. 2005;62:297-302.
19. Onder G, Penninx BW, Lapuerta P, et al. Change in physical performance over time in older women: The Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci. 2002; 57:M289-M293.
20. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379-2388.
21. Bedlack RS, Strittmatter WJ, Morgenlander JC. Apolipoprotein E and neuromuscular disease: a critical review of the literature. Arch Neurol. 2000;57:1561-1565.
22. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049-1060.
23. Collett D. Modelling Survival Data in Medical Research. 2nd ed. Boca Raton, FL: Chapman & Hall; 2003:231-271.
24. SAS. Sas/Stat® User's Guide, Version 8. 8 ed. Cary, NC: SAS Institute Inc; 2000.
25. Aggarwal NT, Wilson RS, Beck TL, et al. The apolipoprotein E Epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase. 2005;11:3-7.
26. Lehericy S, Bardinet E, Tremblay L, et al. Motor control in basal ganglia circuits using FMRI and brain atlas approaches. Cerebral Cortex. 2006;16:149-161.
27. Burke RE, ed. Motor Units: Anatomy, Physiology and Functional Organization. Washington, DC: American Physiological Society; 1981:345-422.
28. Poppele R, Bosco G. Sophisticated spinal contributions to motor control. Trends Neurosci. 2003;26:269-276.
29. Schneider JA, Bienias JL, Wilson RS, et al. The apolipoprotein E Epsilon4 allele increases the odds of chronic cerebral infarction detected at autopsy in older persons. Stroke. 2005;36:954-959.
30. Rosano C, Brach J, Longstreth JWT, et al. Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults. Neuroepidemiology. 2006;26:52-60.
31. Schneider JA, Li JL, Li Y, et al. Substantia Nigra tangles are related to gait impairment in older persons. Ann Neurol. 2006;59:166-173.
32. Wolf DS, Gearing M, Snowdon DA, et al. Progression of regional neuropathology in Alzheimer Disease and normal elderly: findings from the Nun Study. Alzheimer Dis Assoc Disord. 1999;13:226-231.
33. Burns JM, Galvin JE, Roe CM, et al. The pathology of the Substantia Nigra in Alzheimer disease with extrapyramidal signs. Neurology. 2005;64:1397-1403.
34. Horoupian DS, Wasserstein PH. Alzheimer's Disease pathology in motor cortex in dementia with lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol (Berlin). 1999;98:317-322.
35. Formiga F, Alia P, Navarro MA, et al. Apolipoprotein E genotypes in nonagenarians. J Am Geriatr Soc. 2006;54: 1471-1473.
36. Bathum L, Christiansen L, Jeune B, et al. Apolipoprotein E genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians. J Am Geriatr Soc. 2006;54:654-658.
37. Asada T, Yamagata Z, Kinoshita T, et al. Prevalence of dementia and distribution of apoE alleles in Japanese Centenarians: an almost-complete Survey in Yamanashi Prefecture, Japan. J Am Geriatr Soc. 1996;44:151-155.